Memento Medicines, Inc. — Form D

Memento Medicines, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2026-06-16. The offering totals $93.0M, of which $38.0M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2026-06-16
• Form: D
• Accession: 0002139514-26-000002
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $93.0M
• Amount sold: $38.0M
• Remaining: $55.0M
• Investors: 7
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-587553

Issuer

• Name: Memento Medicines, Inc.
• CIK: 0002139514
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 200 BERKELEY ST. 18th Floor, BOSTON, MA, 02116
• Phone: 518-313-0994

Officers, directors & promoters (7)

More

• CIK 2139514 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search